single arm:intraperitoneal perfusion with MTX packaging microparticles

2 trials

Sponsors

Union Hospital of Huazhong University of Science and Technology, Qilu Hospital of Shandong University

Conditions

Recurrent/refractory of ovarian cancer ascitsrecurrent/refractory of ovarian cancer ascites

Early Phase 1

Perspective study for safty and efficacy of methotrexate packaging microparticles in treatment of recrruent/refractory ovarian cancer ascites by peritoneal perfusion

RecruitingChiCTR1900027223

Union Hospital of Huazhong University of Science and Technologyrecurrent/refractory of ovarian cancer ascites

Start: 2019-11-05Updated: 2019-11-11

Perspective study for safty and efficacy of doxorubicin packaging microparticles in treatment of recurrent/refractory ovarian cancer ascites by peritoneal perfusion

RecruitingChiCTR2000033851

Qilu Hospital of Shandong UniversityRecurrent/refractory of ovarian cancer ascits

Start: 2020-06-01Updated: 2020-06-15